Ainos, Inc.: Form 10-Q for the period ended Sep 30, 2014
Filed with the SEC on Nov 14, 2014 and accepted by EDGAR at Nov 13, 2014, 22:34 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-07-01 to 2014-09-30 | $0 | us-gaap:Revenues |
| Cost of revenue | 3 months2014-07-01 to 2014-09-30 | $0 | us-gaap:CostOfRevenue |
| Gross profit | 3 months2014-07-01 to 2014-09-30 | $0 | us-gaap:GrossProfit |
| Research and development | 9 months2014-01-01 to 2014-09-30 | $15.3k | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2014-07-01 to 2014-09-30 | $103.7k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2014-01-01 to 2014-09-30 | $449.7k | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-07-01 to 2014-09-30 | −$103.7k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-01-01 to 2014-09-30 | −$465.0k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-07-01 to 2014-09-30 | $590 | us-gaap:InterestExpense |
| Interest expense | 9 months2014-01-01 to 2014-09-30 | $1.3k | us-gaap:InterestExpense |
| Net income | 3 months2014-07-01 to 2014-09-30 | −$104.3k | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-01-01 to 2014-09-30 | −$466.3k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-07-01 to 2014-09-30 | $0.00 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-01-01 to 2014-09-30 | −$0.01 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2014-07-01 to 2014-09-30 | 73,291,008 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-01-01 to 2014-09-30 | 73,291,008 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-01-01 to 2014-09-30 | −$260.3k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2014-09-30 | $279 | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-09-30 | $34.5k | us-gaap:AssetsCurrent |
| Total assets | At period end2014-09-30 | $122.4k | us-gaap:Assets |
| Current liabilities | At period end2014-09-30 | $5.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-09-30 | $5.4m | us-gaap:Liabilities |
| Shareholders' equity | At period end2014-09-30 | −$5.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001014763-14-000017. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.